title: MRSA meningitis and intrathecal injection of arbekacin.
authors.affiliation: Department of Surgical Neurology, Yamagata University School of Medicine, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Fujita
authors.forename: T
authors.initials: T
authors.lastname: Kayama
authors.forename: I
authors.initials: I
authors.lastname: Sato
authors.forename: H
authors.initials: H
authors.lastname: Fukai
authors.forename: H
authors.initials: H
authors.lastname: Sobue
authors.forename: O
authors.initials: O
authors.lastname: Nakai
mesh_terms: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003982:Dibekacin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D016920:Meningitis, Bacterial / Q000188:drug therapy* / Q000382:microbiology*; D016106:Methicillin Resistance; D008875:Middle Aged; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D003982:Dibekacin; C031986:arbekacin